ATS 2024 Session: Challenges and Opportunities for Early-Stage Drug Development Originating in the Academic Arena

The American Thoracic Society (ATS) 2024 Conference will offer the latest information on clinical, basic, and translational science in pulmonary, critical care, and sleep medicine. If you're attending, catch representatives from the National Heart, Lung, and Blood Institute's Innovation and Commercialization office at the "Challenges and Opportunities for Early-Stage Drug Development Originating in the Academic Arena" session on Sunday, May 19, at 7:00 a.m.

This session will touch on various topics related to translational science and emerging technologies in the respiratory space, which are not traditionally covered under the ATS general programmed material including NIH funding resources specifically for academic entrepreneurs, challenges associated with the commercialization process, how to prepare for biotech/pharma engagement, novel therapeutic approaches and programs from the perspective of successful academic-entrepreneurs, emerging themes and lessons learned with lung-targeting drug delivery, and more.